European Medicines Agency gives green light to immunization of children aged 5 to 11

European Medicines Agency gives green light to immunization of children aged 5 to 11
European Medicines Agency gives green light to immunization of children aged 5 to 11

An 11-year-old child waits after receiving the Pfizer-BioNTech Covid-19 vaccine, in Montreal, Que. On November 24, 2021. ANDREJ IVANOV / AFP

It is the first vaccine against Covid-19 authorized for children in Europe. The European Medicines Agency (EMA) announced Thursday, November 25, that it has approved the use of Pfizer-BioNTech’s messenger RNA vaccine for children aged 5 to 11. At the end of May, she had already authorized its administration to adolescents over 12 years old.

“The benefit of Comirnaty [le nom commercial du vaccin] for children aged 5 to 11 is greater than the risk, especially for those whose condition increases the risk of developing a severe form of Covid-19 ”, explained the European regulator. In order for the Twenty-Seven to be able to launch vaccination campaigns for the youngest, the decision of the EAJ must still be validated by the European Commission, which, in general, follows the advice of the authority.

Read also Vaccination against Covid-19: the High Authority of Health recommends a booster dose for all adults over 18 years old

According to the AEM recommendation, children aged 5 to 11 should receive – in two injections three weeks apart – one third of the dose given to adults and adolescents over 12 years old.

A trial carried out on 2000 young people of this age group made it possible to conclude that the vaccine was 90.7% effective. Of the 1,305 children who were immunized, three developed the disease, compared to sixteen of the 663 who received a placebo. The AEM says it has identified undesirable effects “Light or moderate” comparable to those observed in the elderly: pain at the injection site, fatigue, headache or cold.

The wave of Covid-19 that hit Europe particularly affects children, who are not vaccinated. In this context, class closures are increasing. In the Netherlands, where the AEM is headquartered, those under 12 are the group where the virus is progressing the fastest now, the authorities explained earlier this week.

Read also Article reserved for our subscribers Covid-19: in primary school, the health protocol will be relaxed to limit class closures

“We know that severe Covid-19 and death remain quite rare in children, but serious illness can occur at all pediatric ages”, warned Marco Cavaleri, head of the vaccine strategy of the AEM. Especially since “High transmission leads to increased hospitalizations in children of all ages.”

Collective benefit

In its last assessment of the situation in Europe, on November 24, the European Center for Disease Prevention and Control (ECDC) devoted part of its analysis to the youngest. “Children represent a growing share of those infected and hospitalizations, in part because older populations are increasingly vaccinated”. If the AEM were to approve a vaccine for 5 to 11 year olds, writes the health agency, “The impact on mortality would be negligible in the short term”. But, in the longer term, she continues, “This could have a greater impact on transmission, which would be followed by a drop in mortality and hospitalizations of other age groups”.

You have 51.67% of this article to read. The rest is for subscribers only.

 
For Latest Updates Follow us on Google News
 

PREV PNEA survey: shocking figures for the worrying level of public education
NEXT Investment Commission: 6 projects examined for nearly MAD 4 billion